Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (Action within 48 hours): Karib Kemi Pharm Limited - Multiple Product Drug Alert - Doxazosin 2mg and 4mg Tablets; Fluoxetine 20mg Capsules - EL (09)A/18

Document details:

Type: Drug Alert
Series No: EL (09)A/18
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 4
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

Class 2 medicines recall
Action within 48 hours
Pharmacy and wholesaler level recall
01 July 2009 EL (09)A/18 Our ref:  MDR 58-06/09

Dear Healthcare Professional,

Karib Kemi Pharm Limited

Multiple Product Drug Alert

Doxazosin 2mg and 4mg Tablets; Fluoxetine 20mg Capsules

 

Doxazosin 2mg Tablets (Doxazosin mesilate)

PL 18224/0029

Product in Karib Kemi Pharm Limited livery

Batch Number Expiry Date Pack Size First Distributed
T1D 011007 09/2009 28 29/01/2008
T1D  010408 03/2010 28 16/05/2008
T1D 021108 10/2010 28 09/01/2009
T1D 010509 04/2011 28 29/02/2009
T1D 020509 04/2011 28 29/02/2009

 
Product in Consilient Health Limited livery

Batch Number Expiry Date Pack Size First Distributed
T1D 010108 12/2009 28 07/03/2008
T1D 011108 10/2010 28 09/01/2009


 

Doxazosin 4mg Tablets (Doxazosin mesilate)

PL 18224/0030

Product in Karib Kemi Pharm Limited livery

Batch number Expiry Date Pack Size First Distributed
T2D 010707 06/2009 28 20/12/2007
T2D 020707 06/2009 28 20/12/2007
T2D 010807 07/2009 28 07/04/2008
T2D 020807 07/2009 28 14/07/2008
T2D 010108 12/2009 28 14/07/2008
T2D 010208 01/2010 28 03/11/2008
T2D 010408 03/2010 28 21/10/2008
T2D 020408 03/2010 28 21/10/2008
T2D 040408 03/2010 28 17/11/2008
T2D 011108 10/2010 28 09/01/2009
T2D 010409 03/2011 28 26/05/2009
T2D 010509 04/2011 28 26/05/2009
T2D 020509 04/2011 28 29/02/2009
T2D 030509 04/2011 28 27/05/2009
T2D 040509 04/2011 28 27/05/2009
T2D 050509 04/2011 28 27/05/2009

 

Product in Consilient Health Limited livery

Batch number Expiry Date Pack Size First Distributed
T2D 020108 12/2009 28 04/11/2008

 

Fluoxetine 20mg Capsules (Fluoxetine Hydrochloride)

PL 18224/0059

Product in Karib Kemi Pharm Limited livery

Batch number Expiry Date Pack Size First Distributed
TF8 011208 11/2011 30 13/03/2009
TF8 021208 11/2011 30 01/04/2009
TF8 031208 11/2011 30 01/04/2009
TF8 041208 11/2011 30 01/04/2009
TF8 051208 11/2011 30 01/04/2009
TF8 010109 12/2011 30 27/05/2009
TF8 020109 12/2011 30 27/05/2009
TF8 030109 12/2011 30 27/05/2009
TF8 010209 01/2012 30 27/05/2009
TF8 020209 01/2012 30 27/05/2009
TF8 030209 01/2012 30 27/05/2009
TF8 040209 01/2012 30 08/06/2009


Karib Kemi Pharm Limited are recalling the above products due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

All unused stock of the above batches should be quarantined and returned for credit.

For any Medical Information enquiries related to this case please call Karib Kemi Pharm Limited on 07732 166641 or 07732 166891.

For enquiries related to stock returns and credit for products in Karib Kemi Pharm Limited livery please call Karib Kemi Pharm Limited on 07732 166641 or 07732 166891.

For enquiries related to stock returns for products in Consilient Health Limited livery please call 0208 9562697
For enquiries related to credit for products in Consilient Health Limited livery please call 00353 1 2057753

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are requested to forward this to relevant clinics, General Practitioners and Community Pharmacists.

Yours faithfully
Alison Bunce
Pharmaceutical Assessor, DMRC

MHRA Distribution (further recipients by cascade):

Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)

Page last modified: 01 July 2009